A Diabetes-Specific Enteral Formula Improves Glycemic Variability in Patients with Type 2 Diabetes

Abstract

Relative to the standard formula, the diabetes-specific formula reduced postprandial glycemia, mean glucose, glycemic variability, and short-acting insulin requirements. These results suggest potential clinical usefulness of a diabetes-specific enteral formula for minimizing glycemic excursions in hospitalized patients.